 "Dr Reddy's names ex-Teva official Erez Israeli as COO, global generics head")
Dr Reddy's Laboratories Limited announced a change in the senior leadership team on Thursday, appointed former president and CEO of Enzymotec, Erez Israeli as the chief operating officer and global head of generics and PSAI (pharmaceutical services and active ingredients).
He will replace Abhijit Mukherjee, who is retiring on March 31, 2018 after a 15-year stint in Dr Reddy's.
In a career spanning 25 years, Israeli has held leadership positions that have contributed significantly to the performance of companies he worked for, Dr Reddy's said. Prior to Enzymotec, he completed 23 years with Teva Pharmaceuticals Limited, where he held several positions
